AU2019320488B2 - Uses of curcuminoid compositions - Google Patents
Uses of curcuminoid compositions Download PDFInfo
- Publication number
- AU2019320488B2 AU2019320488B2 AU2019320488A AU2019320488A AU2019320488B2 AU 2019320488 B2 AU2019320488 B2 AU 2019320488B2 AU 2019320488 A AU2019320488 A AU 2019320488A AU 2019320488 A AU2019320488 A AU 2019320488A AU 2019320488 B2 AU2019320488 B2 AU 2019320488B2
- Authority
- AU
- Australia
- Prior art keywords
- curcuminoids
- composition
- curcumin
- extract
- turmeric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Fodder In General (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1812776.1 | 2018-08-06 | ||
| GBGB1812776.1A GB201812776D0 (en) | 2018-08-06 | 2018-08-06 | New methods and uses |
| GBGB1902266.4A GB201902266D0 (en) | 2019-02-19 | 2019-02-19 | New methods and uses |
| GB1902266.4 | 2019-02-19 | ||
| PCT/EP2019/071055 WO2020030612A1 (en) | 2018-08-06 | 2019-08-05 | Uses of curcuminoid compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2019320488A1 AU2019320488A1 (en) | 2021-02-18 |
| AU2019320488B2 true AU2019320488B2 (en) | 2025-01-23 |
Family
ID=67770463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2019320488A Active AU2019320488B2 (en) | 2018-08-06 | 2019-08-05 | Uses of curcuminoid compositions |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US12059394B2 (https=) |
| EP (1) | EP3833337A1 (https=) |
| JP (2) | JP2021534105A (https=) |
| CN (1) | CN112566630A (https=) |
| AU (1) | AU2019320488B2 (https=) |
| BR (1) | BR112021001403A2 (https=) |
| CA (2) | CA3292034A1 (https=) |
| MX (1) | MX2021000776A (https=) |
| WO (1) | WO2020030612A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113208109B (zh) * | 2021-04-30 | 2023-08-29 | 河南中大恒源生物科技股份有限公司 | 一种高生物利用度水溶姜黄素及其制备方法以及应用 |
| CN113383881B (zh) * | 2021-04-30 | 2023-08-29 | 河南中大恒源生物科技股份有限公司 | 一种液体水溶姜黄素及其制备方法以及应用 |
| CN115028886B (zh) * | 2022-06-21 | 2023-11-21 | 贺州学院 | 一种用于检测铅离子的双去甲氧基姜黄素显色薄膜、其制备方法和铅离子快速检测方法 |
| JP2025528917A (ja) * | 2022-08-22 | 2025-09-02 | ジボダン エス エー | クルクミノイド、改変デンプンおよび/またはアカシアガム並びにサポニンを含む医薬用組成物 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2671596A1 (en) * | 2011-01-31 | 2013-12-11 | Wacker Chemie AG | Process for producing aqueous solution containing fat-soluble substance |
| US20160081927A1 (en) * | 2014-09-18 | 2016-03-24 | Virun, Inc. | Pre-spray emulsions and powders containing non-polar compounds |
| WO2018083677A1 (en) * | 2016-11-07 | 2018-05-11 | Akay Flavours & Aromatics Pvt. Ltd. | Green approach in enhancing the bioavailability of oils, fats and other lipophilic bioactives and compositions thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2786775B1 (fr) * | 1998-12-04 | 2001-02-16 | Roquette Freres | Maltodextrines branchees et leur procede de preparation |
| JP5448511B2 (ja) * | 2008-03-31 | 2014-03-19 | 三栄源エフ・エフ・アイ株式会社 | ウコン色素組成物及びその調製方法 |
| JP2011130696A (ja) * | 2009-12-24 | 2011-07-07 | Nihon Cornstarch Corp | マルトデキストリンの製造方法 |
| EP2359702B1 (en) * | 2010-01-22 | 2014-06-04 | Symrise AG | Solubilization agent for solubilizing polyphenols, flavonoids and/or diterpenoid glucosides |
| DE102011056111B4 (de) * | 2011-12-06 | 2013-08-14 | Sensient Colors Europe Gmbh | Emulsion |
| DK2721933T3 (da) * | 2012-10-16 | 2017-11-20 | DÖHLER GmbH | Emulsion |
| WO2014202364A1 (en) * | 2013-06-21 | 2014-12-24 | Firmenich Sa | Preparation of dried particles comprising menthol |
| US20160151440A1 (en) * | 2013-08-19 | 2016-06-02 | Aurea Biolabs Private Limited | A Novel Composition of Curcumin with Enhanced Bioavailability |
| KR20180124133A (ko) * | 2016-04-01 | 2018-11-20 | 산에이겐 에후.에후. 아이. 가부시키가이샤 | 고체 색소의 안정화 방법 |
| JP6794190B2 (ja) * | 2016-09-01 | 2020-12-02 | 株式会社ファンケル | キマーゼ阻害用組成物 |
| WO2018056444A1 (ja) * | 2016-09-26 | 2018-03-29 | 三栄源エフ・エフ・アイ株式会社 | クルクミン組成物 |
| JP6986345B2 (ja) * | 2016-11-18 | 2021-12-22 | ロート製薬株式会社 | 経口組成物及びその製造方法 |
-
2019
- 2019-08-05 WO PCT/EP2019/071055 patent/WO2020030612A1/en not_active Ceased
- 2019-08-05 CA CA3292034A patent/CA3292034A1/en active Pending
- 2019-08-05 CN CN201980052384.2A patent/CN112566630A/zh active Pending
- 2019-08-05 US US17/266,320 patent/US12059394B2/en active Active
- 2019-08-05 EP EP19759301.5A patent/EP3833337A1/en active Pending
- 2019-08-05 AU AU2019320488A patent/AU2019320488B2/en active Active
- 2019-08-05 CA CA3108123A patent/CA3108123A1/en active Pending
- 2019-08-05 MX MX2021000776A patent/MX2021000776A/es unknown
- 2019-08-05 BR BR112021001403-9A patent/BR112021001403A2/pt unknown
- 2019-08-05 JP JP2021506662A patent/JP2021534105A/ja active Pending
-
2023
- 2023-11-13 US US18/388,981 patent/US12220388B2/en active Active
-
2024
- 2024-08-23 JP JP2024143155A patent/JP2025003947A/ja active Pending
-
2025
- 2025-01-07 US US19/012,674 patent/US20250144048A1/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2671596A1 (en) * | 2011-01-31 | 2013-12-11 | Wacker Chemie AG | Process for producing aqueous solution containing fat-soluble substance |
| US20160081927A1 (en) * | 2014-09-18 | 2016-03-24 | Virun, Inc. | Pre-spray emulsions and powders containing non-polar compounds |
| WO2018083677A1 (en) * | 2016-11-07 | 2018-05-11 | Akay Flavours & Aromatics Pvt. Ltd. | Green approach in enhancing the bioavailability of oils, fats and other lipophilic bioactives and compositions thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| US20250144048A1 (en) | 2025-05-08 |
| CA3108123A1 (en) | 2020-02-13 |
| JP2025003947A (ja) | 2025-01-14 |
| MX2021000776A (es) | 2021-06-15 |
| JP2021534105A (ja) | 2021-12-09 |
| BR112021001403A2 (pt) | 2021-04-27 |
| KR20210041037A (ko) | 2021-04-14 |
| AU2019320488A1 (en) | 2021-02-18 |
| WO2020030612A1 (en) | 2020-02-13 |
| EP3833337A1 (en) | 2021-06-16 |
| US12059394B2 (en) | 2024-08-13 |
| US20220280448A1 (en) | 2022-09-08 |
| CN112566630A (zh) | 2021-03-26 |
| CA3292034A1 (en) | 2026-03-02 |
| US20240115519A1 (en) | 2024-04-11 |
| US12220388B2 (en) | 2025-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019320487B2 (en) | Curcuminoid compositions | |
| US12220388B2 (en) | Uses of curcuminoid compositions | |
| Jawahar et al. | Enhanced oral bioavailability of an antipsychotic drug through nanostructured lipid carriers | |
| AU2011368608B2 (en) | A water soluble composition comprising curcumin having enhanced bioavailability and process thereof | |
| Wang et al. | Micellization of coenzyme Q by the fungicide caspofungin allows for safe intravenous administration to reach extreme supraphysiological concentrations | |
| Abhilash et al. | Enhanced absorption of curcuminoids and 3-Acetyl-11-keto-β-boswellic acid from fenugreek galactomannan hydrogel beadlets: A natural approach to the co-delivery of lipophilic phytonutrients | |
| Hundshammer et al. | Enhanced metabolic bioavailability of tetrahydrocurcumin after oral supplementation of a γ-cyclodextrin curcumin complex | |
| V. Ambardekar et al. | Enhancement of hepatoprotective efficacy of propolis by fabrication of liposomes, as a platform nano-formulation for multi-component natural medicine | |
| KR20230116674A (ko) | 안정화된 테트라하이드로커큐민을 함유하는 아토피 피부염 개선용 식품조성물 | |
| Gabriele et al. | Encapsulation of bioactive fermented wheat (Lisosan G) in Eudragit-liposomes | |
| US20170072004A1 (en) | Compositions and methods for improving the bioavailability of curcuminoids | |
| KR102957602B1 (ko) | 커큐미노이드 조성물의 용도 | |
| US20220193008A1 (en) | Bioaccessibile compositions of lipophilic compounds and process thereof | |
| BR112021001405B1 (pt) | Composição de curcuminoide, seu uso, processo para sua preparação, e produtos compreendendo tal composição | |
| KR20200101062A (ko) | 진세노사이드 흡수율 증진용 복합체 및 그의 제조 방법 | |
| WO2004071496A1 (de) | Liponsäure-haltige orale darreichungsform zur kolon-spezifischen wirkstofffreisetzung | |
| Ruan et al. | Ameliorative Hypoglycemic Effect of 1-DNJ via Structural Derivatization Followed by Assembly Into Selenized Nanovesicles | |
| Rimsueb et al. | Oral delivery of Kaempferia parviflora's methoxyflavones via nanostructured lipid carriers: Its effect on obesity and dyslipidemia treatment” | |
| EP4247343A1 (de) | Mizellares system zum transport von wirkstoffen | |
| US20190290669A1 (en) | N-palmitoyl-d-glucosamine in a micronized form |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |